Literature DB >> 19307546

NMO-IgG detected in CSF in seronegative neuromyelitis optica.

E C Klawiter1, E Alvarez, J Xu, A R Paciorkowski, L Zhu, B J Parks, A H Cross, R T Naismith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19307546      PMCID： PMC2677472          DOI： 10.1212/01.wnl.0000345066.57745.50

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  An open label study of the effects of rituximab in neuromyelitis optica.

Authors:  B A C Cree; S Lamb; K Morgan; A Chen; E Waubant; C Genain
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

2.  Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.

Authors:  Brian G Weinshenker; Dean M Wingerchuk; Sandra Vukusic; Linda Linbo; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

3.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

4.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

5.  NMO-IgG predicts the outcome of recurrent optic neuritis.

Authors:  M Matiello; V A Lennon; A Jacob; S J Pittock; C F Lucchinetti; D M Wingerchuk; B G Weinshenker
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

Review 6.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

7.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307
  7 in total
  25 in total

1.  CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG.

Authors:  Andrew McKeon; Sean J Pittock; Vanda A Lennon
Journal:  Neurology       Date:  2011-03-22       Impact factor: 9.910

2.  Intramedullary Sjögren syndrome.

Authors:  S Chahin; M D Garwood; E K St Louis; E Torage Shivapour; P M Kelkar; M A Granner
Journal:  Neurology       Date:  2009-12-08       Impact factor: 9.910

Review 3.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

4.  [Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group].

Authors:  C Trebst; A Berthele; S Jarius; T Kümpfel; S Schippling; B Wildemann; C Wilke
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

5.  Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.

Authors:  Gulsen Akman-Demir; Erdem Tüzün; Patrick Waters; Sema Içöz; Murat Kürtüncü; Sven Jarius; Zuhal Yapıcı; Melike Mutlu; Nilüfer Yeşilot; Angela Vincent; Mefkure Eraksoy
Journal:  J Neurol       Date:  2010-10-17       Impact factor: 4.849

Review 6.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

7.  Bilateral Internuclear Ophthalmoplegia in a Patient with Devic's Neuromyelitis Optica.

Authors:  E Garcia-Martin; I Pinilla; V Pueyo; L Gil; J Martinez-Morales; J Fernandez
Journal:  Case Rep Neurol       Date:  2010-11-12

8.  Paraneoplastic and other autoimmune disorders of the central nervous system.

Authors:  Andrew McKeon
Journal:  Neurohospitalist       Date:  2013-04

9.  Innocent Until Proven Guilty.

Authors:  Heather E Moss; Tiffani S Stroup; Amy Y Lin; Oliver W Graf; Aaron M Halfpenny; Howard L Lipton; Ari M Blitz; Tibor Valyi-Nagy
Journal:  J Neuroophthalmol       Date:  2016-03       Impact factor: 3.042

Review 10.  The treatment of neuromyelitis optica.

Authors:  Markus C Kowarik; John Soltys; Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2014-03       Impact factor: 3.042
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.